ID: ALA4793576

Max Phase: Preclinical

Molecular Formula: C14H18N2O

Molecular Weight: 230.31

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CC2NCC3c4cccc(=O)n4CC2C31

Standard InChI:  InChI=1S/C14H18N2O/c1-8-5-11-10-7-16-12(3-2-4-13(16)17)9(6-15-11)14(8)10/h2-4,8-11,14-15H,5-7H2,1H3/t8-,9?,10?,11?,14?/m1/s1

Standard InChI Key:  XJHYAVIQMMKYJG-MTXFGMJDSA-N

Associated Targets(Human)

Neuronal acetylcholine receptor; alpha4/beta2 3972 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 230.31Molecular Weight (Monoisotopic): 230.1419AlogP: 1.19#Rotatable Bonds: 0
Polar Surface Area: 34.03Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.96CX LogP: 0.32CX LogD: -2.16
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.73Np Likeness Score: 0.80

References

1. Lin SX,Curtis MA,Sperry J.  (2020)  Pyridine alkaloids with activity in the central nervous system.,  28  (24): [PMID:33120080] [10.1016/j.bmc.2020.115820]

Source